The concept that substances from intestinal contents, passing into the general circulation, may cause toxic symptoms has been of particular interest in the study of liver disease. In 1896, Nencki, Pawlow, and Zaleski (1) demonstrated that diversion of portal blood, containing large amounts of ammonium, into the general circulation by an Eck fistula resulted in an increase in ammonium content of peripheral blood. In cirrhosis of the liver and in patients with porta-caval anastomoses elevation of blood ammonium has frequently been found and in some cases correlated with neurological disturbances (2) (3) (4) (5) (6) (7) (8) (9) (10) .
The reason for the elevation of blood ammonium in these cases has not been determined precisely. Van Caulaert, Deviller, and Halff (3, 10) suggested that in cirrhosis this abnormality of ammonium was related to the presence of portal collateral veins with shunting of portal blood directly into the systemic circulation. Kirk (2) supported this hypothesis with extensive studies.
To evaluate the roles of portal collateral circulation and of liver function in the control of blood ammonium levels, simultaneous sampling from antecubital and hepatic veins has been undertaken.
To accentuate differences in ammonium content at these sites, and to test patients' ability to metabolize ammonium, a standard dose of ammonium chloride has been given by mouth. The results of such investigations, with corollary observations, form the basis of this report.
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A note on the measurement of ammonium in the blood The measurement of blood ammonium is a flight after a Will-o'-th'-wisp (11) , for it is generally agreed that ammonium is liberated as soon as blood is shed. Therefore, any single measurement made after drawing blood represents only a point on an ascending line of ammonium concentration.
By making timed serial determinations on the same sample of blood Conway and Cooke (12, 13) were able to construct a graph expressing the evolution of ammonium. From this graph, by extrapolation, they estimated the ammonium level at zero time, and concluded that there was no measurable ammonium in the circulating blood of normal individuals; they stressed that what was frequently measured as blood ammonium was in reality ammonium which had been liberated from other substances after the blood was drawn.
Conway and Cooke (13) found that blood drawn in an atmosphere of CO2 did not liberate ammonium immediately, and suggested that CO2 inhibited the breakdown of adenosine, which they had found to be the major source of the immediately liberated ammonium (14) . Strehler, Haas, and Rupp (15) reported similar results and found that an atmosphere of CO2 would decrease the ammonium content of blood drawn in air. This depression of ammonium liberation was presumed to act through an inhibition of an enzyme deaminating adenosine. Kalckar (16) found that CO2 did not inhibit the deamination of adenosine by adenosine deaminase, nor did it catalyse reamination. In the present study no consistent significant inhibition of ammonium formation by CO2 could be demonstrated. Other workers (6, 17) even though taking blood in an atmosphere of CO2 have found high levels of ammonium in normal 158 blood, suggesting that CO2 failed to inhibit ammonium liberation. We were also unable to suppress ammonium liberation by AgNO3 which Zittle (18) found completely inhibited adenosine deaminase. Accordingly, in the results reported here blood was drawn in air, and no attempt to inhibit ammonium liberation was made.
In the present study the technique of serial ammonium determinations on the same blood sample has been used. Each determination was timed from the moment of beginning the collection of blood until an aliquot was pipetted into the diffusion chamber. Six analyses were made on each sample, and a graph was constructed expressing the changing concentration of ammonium. The extrapolated zero-time ammonium was determined, and the observations on 21 control subjects without hepatic disease (including 15 normals) supported Conway's conclusion that in the fasting subject without liver disease there is no measurable free ammonium in the circulating blood ( Figure 1 ). A check was kept on two time intervals; the first the elapsed time between drawing the blood and pipetting into the units, and the second the fifteen-minute incubation period. The latter was chosen as convenient for our purposes, yet well below the time when ammonium may be liberated from glutamine.
As a check on NH4Cl absorption, as well as to meas- (20) . Three other patients who had cirrhosis without demonstrable portal collateral vessels were also studied.
IV. Miscellaneous, 8 cases. This diverse group included two with obstructive jaundice due to carcinoma, two with nephritis (one of whom was uremic), two with hepatosplenomegaly and normal liver function tests, one of whom had a normal liver biopsy. The other had abdominal tuberculosis. One patient presented the Chiari syndrome with invasion of the inferior vena cava and hepatic veins by renal carcinoma. One patient had a thrombosed portal vein following pylephlebitis, with esophageal varices and a normal liver by biopsy and function tests.
One patient with cirrhosis and two with normal liver function received no NHICI, but had serial determinations of blood ammonium throughout the day while fasting to investigate diurnal variation. The neurological signs and symptoms associated with liver disease have been extensively reviewed and are not described here. Of the patients investigated ten had sach neurological changes associated with hepatitis or cirrhosis and are fully described elsewhere (9) .
RESULTS
The mean "three-minute" fasting blood ammonium value in 21 control patients without liver disease was 0.79 ,ug. per ml., Standard Deviation 0.09.
In two patients with renal disease and normal liver function tests and one patient with cirrhosis and esophageal varices, one-half to two hourly blood samples were taken throughout the day while the patient fasted, and the fluctuation of ammonium levels was found not to exceed 0.1 ,ug.
per ml. in antecubital or hepatic vein blood.
In seven resting control subjects simultaneous artery and vein blood samples were obtained from an extremity, and no significant difference in ammonium content at these two sites was observed. Other workers have reported similar results (21, 22) .
In five patients the values for portal venous blood ammonium, obtained at laparotomy or from abdominal wall collaterals, averaged 2.7 times those for peripheral blood (Table I) . In a further patient (Ru) blood from a gastric vein was Hepatitis. Four of the five patients studied during the acute phase of viral hepatitis showed elevated peripheral and hepatic vein ammonium levels in control specimens (Figure 2 ). In three of the four the hepatic vein ammonium content exceeded that of the antecubital vein blood. This became particularly marked after NH,C1 ingestion, when the rise in ammonium values in hepatic vein blood far surpassed that of peripheral vein blood. Further, the return to control values was delayed, and ammonium levels were above con-hepatitis, whose only abnormal liver function test trol at 120 minutes in both peripheral and hepatic was an elevated bilirubin, but who had biopsy vein blood. The one real exception to these find-evidence of hepatitis. These data suggested ings was in a patient with mild, though acute that in patients with severe hepatitis ammonium Figure 4 ). This response demonstrated the importance of collateral channels in the production of abnormal ammonium tolerance in some patients with good liver function. Conversely, in an additional patient with cirrhosis, portal collateral veins and poor liver function (elevated bilirubin, abnormal thymol turbidity and low serum albumin), a marked increase in ammonium levels in blood followed the ingestion of NH4C1 and was more marked in hepatic vein blood than in peripheral vein blood. Ammonium values at both sites were above the fasting at 120 minutes (Case Can, Figure 5) . This case demonstrated that in cirrhosis with poor liver function NH4 may pass through the damaged liver into the general circulation.
Miscellaneous. Two patients with obstructive jaundice due to carcinoma showed elevated peripheral vein ammonium levels in control, 30 and 60- minute specimens, but 120-minute values were below the fasting levels. The hepatic vein NH4 values were within normal limits (Table III) . One patient with nephritis showed a normal ammonium tolerance curve in peripheral vein blood. A second patient, with nephritis and uremia (blood urea 418 mg. per 100 ml.) had a fall in peripheral blood NH, after NH4C1 ingestion, with a late rise (Table III) .
The two patients with hepatosplenomegaly and normal liver function tests showed ammonium tolerance tests within normal limits in both peripheral and hepatic vein blood.
The patient with the Chiari syndrome had an elevated blood NH4 in the fasting peripheral vein blood, and this rose higher 60 minutes after the ingestion of NH4Cl.
The patient with normal liver, thrombosed portal vein and extensive esophageal varices secondary to pylephlebitis, had an elevated NH4 response in peripheral vein blood after NH4Cl. The hepatic vein figures were within normal limits (Table III) .
None of the patients in this miscellaneous group had neurological symptoms at any time before or after NH4C1 ingestion.
Blood glutamine studies
In seven control subjects there was no consistent or significant change in glutamine content of peripheral or hepatic vein blood after NH4C1 ingestion (Table IV) . Similarly, in fourteen patients with cirrhosis there was no consistent response in blood glutamine to the administration of NH,Cl by mouth. Individual cases varied widely, but averages showed no significant differences. Values below those of peripheral vein blood were obtained in two patients from renal vein blood.
Blood urea studies Blood urea increased in seven control subjects and in fourteen patients with cirrhosis after NH4C1 ingestion (Table V) . Quantitatively the total rise was equal in the two groups, and the rate of rise was similar ( Figure 6 ).
DISCUSSION
The data presented suggest two main sources of what is presently measured as blood ammonium in resting subjects: 1) The gastrointestinal tract; and 2) the kidneys. These results agree with previously published observations (1, 2, 21, 22) .
The proof that a substance, or substances, from intestinal contents may provoke systemic disturbances must rest on three factors: 1) That the material must be absorbed in sufficient quantity from the intestine; 2) that it must then enter the general circulation in abnormal amounts; and 3) provoke toxic manifestations.
The data reported here confirm that NH4C1 fulfills the first two of these requirements in patients with severe liver disease. The high fasting level of ammonium in portal blood and its rapid rise after an oral dose of NH4Cl prove its rapid absorption (23) .
The small increase in peripheral blood ammonium levels after NH4Cl ingestion in control subjects is in marked contrast to results observed in patients with liver disease. In patients with severe acute hepatitis, or cirrhosis with poor liver function, the normal high gradient between ammonium content of portal and hepatic venous blood is diminished, and large amounts of ammonium reach the general circulation through the liver. In patients with good liver function, but with extensive portal collateral circulation, high peripheral blood ammonium levels may follow the ingestion of NH4C1. In these patients, however, the NH. gradient from portal to hepatic venous blood is normal, indicating that ammonium entered the peripheral circulation through some route other than hepatic veins, probably through the portal collateral channels. In patients with poor liver function and portal collateral veins both routes exist, and high levels of ammonium are found in peripheral blood. These results demonstrate the pathways taken by ammonium from intestine to peripheral blood, and confirm for NH4Cl the second of the above factors.
Evidence was also obtained for the third factor, that NH4Cl is, in fact, toxic. Five patients showed accentuation of neurological disturbances during the NH4Cl tolerance test. Such symptoms were found only in those patients in whom the NH, levels remained elevated for a considerable period. Not all of the patients with prolonged high peripheral blood ammonium levels developed neurological symptoms, and such disturbances occurred in others when blood ammoniumi was only moderately elevated (9) . There was no evidence of acidosis in any patient (9) .
It is, at present, impossible to state that ammonium itself is the toxic substance, or to explain the mechanism of toxicity. It is certain that ammonium, or some material derived from it, can produce toxic changes in the central nervous system. Other nitrogenous substances may have a similar effect (6).
The rise in ammonium level of hepatic vein blood after an oral dose of NH4Cl is a sensitive index of the capacity of the liver to metabolize ammonium, and therefore of hepatocellular function.
The present investigation cast no light on the metabolic abnormality in these patients. In the patients with portal collateral veins, the shunting of blood away from the normal site of ammonium metabolism could itself be responsible for high NH4 levels in peripheral blood. In the presence of poor liver function, however, some abnormality in the metabolism of NH4 in the liver is obvious. Little can be deduced of the role of glutamine synthesis in this mechanism from the present data.
Glutamine is, however, quantitatively of minor importance as an end product of ammonium metabolism. Of far more importance is urea, the formation of which is primarily an hepatic function (24, 25) . In these studies no difference between nor-mal and cirrhotic subjects was found in the ability to synthesize urea.
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